Understanding Immunotherapy for Early-Stage TNBC

Options
Moderators
Moderators Member Posts: 25,912

Immunotherapy for Early-Stage Triple-Negative Breast Cancer: Understanding What Appear to Be Conflicting Results
December 19, 2019

Results from two studies on using the immunotherapy medicines Tecentriq or Keytruda along with chemotherapy to treat early-stage triple-negative breast cancer before surgery suggested that Keytruda offered benefits while Tecentriq did not. Read more...

Categories